Vivos (RDGL) Change in Intangibles (2012 - 2013)
Vivos' (RDGL) quarterly Change in Intangibles came in at $9754.0 in Q1 2013, down 44.26% year-on-year from $17500.0 in Q1 2012, and down 44.26% quarter-over-quarter from $17500.0 in Q1 2012.
Vivos (RDGL) Change in Intangibles (2012 - 2013) Analysis & Trends
Vivos has disclosed Change in Intangibles across 2 years of filings, most recently posting $9754.0 for Q1 2013.
- Change in Intangibles for Q1 2013 came in at $9754.0, down 44.26% year-over-year; the trailing twelve-month figure through Mar 2015 was $27254.0 (changed N/A YoY), and the FY2010 annual result was $20000.0, changed N/A from the prior year.
- Change in Intangibles came in at $9754.0 for Q1 2013 at Vivos, down from $17500.0 in the prior quarter.
- In the past five years, Change in Intangibles ranged from a high of $17500.0 in Q1 2012 to a low of $9754.0 in Q1 2013.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Vivos | - | - | -3,105.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2013 | 9,754.00 |
| Mar 31, 2013 | 9,754.00 |
| Mar 31, 2012 | 17,500.00 |
| Mar 31, 2012 | 17,500.00 |